Abraxis BioScience, LLC

FDA inspection history in Phoenix, Arizona, 2018 to 2023

4
Form 483s
1
Warning letter
1
Close-out

Every document, by year

  • Form 483
  • Warning letter
  • Close-out

2018: one Form 483; 2020: one Form 483; 2022: one warning letter and one Form 483; 2023: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2018–23Four Form 483s and one warning letter, at Phoenix, Arizona.
  2. 2023The longest 483 on file: 6 observations over 4 pages at Phoenix, Arizona.

Cited most

Across all Abraxis BioScience observations on file

The complete Abraxis BioScience file.

All 6 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$505$594

15% off buying them one by one

Sites

Documents

6 on file, newest first
DateDocumentPrice
2023-10-06483 Form 483$99
2022-10-31Warning letter Warning letter$99
2022-04-06483 Form 483$99
2020-02-19483 Form 483$99
2018-08-17483 Form 483$99
UndatedClose-out Close-out letter$99

FEI number 3006441852 · most recent document Oct 6, 2023

About Abraxis BioScience, LLC

How many FDA Form 483s has Abraxis BioScience, LLC received?

FDA Intel has 4 Form 483s on file for Abraxis BioScience, LLC; the most recent is dated Oct 6, 2023.

When was Abraxis BioScience, LLC last inspected by FDA?

The most recent FDA inspection document on file for Abraxis BioScience, LLC is a Form 483 dated Oct 6, 2023, for the site in Phoenix, Arizona.

What did FDA cite at Abraxis BioScience, LLC?

The regulations cited most in the observations on file for Abraxis BioScience, LLC are 21 CFR 211.192 (Production record review), 3 times; 21 CFR 211.100(b) (Written procedures; deviations), 2 times; 21 CFR 211.68(b) (Automatic, mechanical, and electronic equipment), 2 times.

Has Abraxis BioScience, LLC received an FDA warning letter?

Yes. FDA Intel has 1 FDA warning letter on file for Abraxis BioScience, LLC; the most recent is dated Oct 31, 2022.